In trading on Friday, shares of Medicines Co (MDCO) touched a new 52-week high of $45.31/share. That's a 64.76% rise, or $17.81 per share from the 52-week low of $27.50 set back on 02/11/2016. That means at today's intraday high, any investor who purchased MDCO stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, MDCO has seen 2 different instances of insiders buying over the trailing six month period.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
12/08/2016 Fredric N. Eshelman Director 621,720 $33.77 $20,993,462.41
12/08/2016 Christopher T. Cox EVP & Chief Corp. Dev. Officer 105,500 $33.20 $3,502,950.00

The chart below shows where MDCO has traded over the past year, with the 50-day and 200-day moving averages included.

Medicines Co  Moving Averages Chart

In afternoon trading on Friday, MDCO shares are changing hands at $44.90/share, slightly below the new 52-week high.

More from Stocks

Stocks Show Signs of Life During Fed Chair Powell's Testimony on Capitol Hill

Stocks Show Signs of Life During Fed Chair Powell's Testimony on Capitol Hill

Jim Cramer: Bank of America Expects 4% Economic Growth in Q2

Jim Cramer: Bank of America Expects 4% Economic Growth in Q2

Jim Cramer Reacts to Lloyd Blankfein's Retirement at Goldman Sachs

Jim Cramer Reacts to Lloyd Blankfein's Retirement at Goldman Sachs

Jim Cramer: Netflix Pulls Down All of FANG

Jim Cramer: Netflix Pulls Down All of FANG

Goldman Sachs Solves the Great Mystery Behind Oil Stocks

Goldman Sachs Solves the Great Mystery Behind Oil Stocks